01 August 2006
Photodynamic effects of pyropheophorbide-a methyl ester in nasopharyngeal carcinoma cells
Chuan Shan Xu, Albert Wing Nang LeungMed Sci Monit 2006; 12(8): BR257-262 :: ID: 452845
Abstract
Background:Nasopharyngeal carcinoma (NPC) is one of the most common cancers, and exploring novel therapeutic modalities will improve the clinical outcomes. It has been confirmed that photodynamic therapy can efficiently deactivate malignant cells. The aim of the present study was to explore the photodynamic effects of pyropheophorbide-a methyl ester (MPPa) in CNE2 nasopharyngeal carcinoma cells.
Material/Methods: CNE2 cells were subjected to photodynamic therapy with MPPa, in which the drug concentration was 0.25 to 4 µM and light energy 1 to 8 J/cm[sup]2[/sup]. Photodynamic toxicity was investigated 24 h after treatment. Apoptosis was determined using flow cytometry with annexin V-FITC and propidum iodine staining and with nuclear staining with Hoechst 33258. The mitochondrial membrane potential (ΔΨm) was evaluated by Rhodamine 123 assay.
Results: There was no dark cytotoxicity of MPPa in the CNE2 cells at doses of 0.25–4 µM, and MPPa resulted in dose- and light-dependent phototoxicity. The apoptotic rate 8 h after PDT with MPPa (2 µM) increased to 16.43% under a light energy of 2 J/cm[sup]2[/sup]. Mitochondrial membrane potential (ΔΨm) collapsed when the CNE2 cells were exposed to 2 µM MPPa for 20 h and then 2 J/cm[sup]2[/sup] irradiation.
Conclusions:Photodynamic therapy with MPPa significantly enhanced apoptosis and the collapse of ΔΨm. This can be developed for treating nasopharyngeal carcinoma.
Keywords: Cell Death - drug effects, Membrane Potentials - drug effects, Mitochondrial Membranes - drug effects, Nasopharyngeal Neoplasms - drug therapy, Photochemotherapy - methods, Photosensitizing Agents - therapeutic use, Porphyrins - therapeutic use, Tumor Cells, Cultured
Editorial
01 January 2026 : Editorial
Editorial: Increasing Awareness of Lung Cancer in Non-Smokers and Never-Smokers Challenges Current Approaches to Prevention and ScreeningDOI: 10.12659/MSM.952454
Med Sci Monit 2026; 32:e952454
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






